{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:24:57Z","timestamp":1780061097856,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.chest.2022.05.038","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T21:38:32Z","timestamp":1655242712000},"page":"1147-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anticoagulation for VTE"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-005X","authenticated-orcid":false,"given":"Steve Raoul","family":"Noumegni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Le Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"de Moreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Le Moigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tromeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mansourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Gentric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Guegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Poulhazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bressollette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-8032","authenticated-orcid":false,"given":"Francis","family":"Couturaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2022.05.038_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"suppl 4","key":"10.1016\/j.chest.2022.05.038_bib2","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"issue":"9","key":"10.1016\/j.chest.2022.05.038_bib3","first-page":"117","article-title":"Arterial cardiovascular events and mortality following venous thromboembolism","volume":"3","author":"Adelborg","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.chest.2022.05.038_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2021.05.009","article-title":"Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: a systematic review and meta-analysis of cohort studies","volume":"203","author":"Noumegni","year":"2021","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.chest.2022.05.038_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-0041-1733923","article-title":"Cardiovascular mortality after venous thromboembolism: a meta-analysis of prospective cohort studies","volume":"48","author":"Noumegni","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.chest.2022.05.038_bib6","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/124610","article-title":"Venous thromboembolism: classification, risk factors, diagnosis, and management","volume":"2011","author":"Moheimani","year":"2011","journal-title":"ISRN Hematol"},{"issue":"3","key":"10.1016\/j.chest.2022.05.038_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2022.05.038_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.05.038_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.chest.2022.05.038_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE Randomized Clinical Trial","volume":"314","author":"Couturaud","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.chest.2022.05.038_bib11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3324\/haematol.2018.210971","article-title":"Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial","volume":"104","author":"Couturaud","year":"2019","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.chest.2022.05.038_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/jth.14458","article-title":"Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; a cohort study","volume":"17","author":"Kearon","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"26","key":"10.1016\/j.chest.2022.05.038_bib13","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"EINSTEIN","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2022.05.038_bib14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.chest.2022.05.038_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/ATVBAHA.118.310955","article-title":"Novel antiplatelet therapies for atherothrombotic diseases","volume":"39","author":"Majithia","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.chest.2022.05.038_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.thromres.2012.08.296","article-title":"Lipid lowering drugs and the risk of recurrent venous thromboembolism","volume":"130","author":"Delluc","year":"2012","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.chest.2022.05.038_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-128-8-199804150-00011","article-title":"Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative","volume":"128","author":"Kearon","year":"1998","journal-title":"Ann Intern Med"},{"issue":"26","key":"10.1016\/j.chest.2022.05.038_bib18","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1056\/NEJMcp0804570","article-title":"Clinical practice. Acute pulmonary embolism","volume":"359","author":"Konstantinides","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.chest.2022.05.038_bib19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.acvd.2017.08.005","article-title":"Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: insights from the ORBI registry","volume":"111","author":"Pimor","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.chest.2022.05.038_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010541","article-title":"Association of major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean population","volume":"8","author":"Choi","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.chest.2022.05.038_bib21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2022.05.038_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000059","volume":"13","author":"Dehmer","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.chest.2022.05.038_bib23","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.chest.2022.05.038_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.chest.2022.05.038_bib25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pst.2130","article-title":"Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events","volume":"20","author":"Stegherr","year":"2021","journal-title":"Pharm Stat"},{"issue":"3","key":"10.1016\/j.chest.2022.05.038_bib26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"5","key":"10.1016\/j.chest.2022.05.038_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005466","article-title":"Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events","volume":"6","author":"Chang","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.chest.2022.05.038_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jvsv.2019.03.011","article-title":"Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: findings from the Registro Informatizado de Enfermedad Tromboemb\u00f3lica Registry","volume":"8","author":"Golemi","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"12","key":"10.1016\/j.chest.2022.05.038_bib29","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","article-title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","volume":"123","author":"Kearon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.chest.2022.05.038_bib30","first-page":"CD002001","article-title":"Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism","volume":"10","author":"Andras","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.chest.2022.05.038_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejvs.2014.05.001","article-title":"Editor\u2019s choice\u2014efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials","volume":"48","author":"Kakkos","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.05.038_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2022.05.038_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002665","article-title":"Increased peripheral arterial calcification in patients receiving warfarin","volume":"5","author":"Han","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.chest.2022.05.038_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cells10040773","article-title":"The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: a review","volume":"10","author":"Elango","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.chest.2022.05.038_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jvsv.2014.11.002","article-title":"Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism","author":"Madridano","year":"2015","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922201087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922201087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:44:43Z","timestamp":1757925883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922201087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S001236922201087X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.05.038","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for VTE","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}